UPLOAD Filing
Entera Bio Ltd.
Date: June 4, 2025 · CIK: 0001638097 · Accession: 0000000000-25-005894
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287676
Letter
Re: Entera Bio Ltd. Registration Statement on Form S-3 Filed May 30, 2025 File No. 333-287676 Dear Miranda Toledano:
June 4, 2025
Miranda Toledano Chief Executive Officer Entera Bio Ltd. Kiryat Hadassah Minrav Building - Fifth Floor Jerusalem, Israel 9112002
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jason Drory at 202-551-8342 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Sami B. Ghneim, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> June 4, 2025 Miranda Toledano Chief Executive Officer Entera Bio Ltd. Kiryat Hadassah Minrav Building - Fifth Floor Jerusalem, Israel 9112002 Re: Entera Bio Ltd. Registration Statement on Form S-3 Filed May 30, 2025 File No. 333-287676 Dear Miranda Toledano: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Sami B. Ghneim, Esq. </TEXT> </DOCUMENT>